Cargando…

IDO in Colorectal Tumorigenesis: Involvement of Immune Tolerance and Significance in Prevention and Therapy

Detalles Bibliográficos
Autores principales:	Tang, Shunan, Wang, Jingya, Yu, Siwang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8531978/ https://www.ncbi.nlm.nih.gov/pubmed/34280382 http://dx.doi.org/10.1016/j.jcmgh.2021.06.021

Ejemplares similares

Impact of IDO1 and IDO2 on the B Cell Immune Response
por: Merlo, Lauren M. F., et al.
Publicado: (2022)

IDO1(+) Paneth cells promote immune escape of colorectal cancer
por: Pflügler, Sandra, et al.
Publicado: (2020)

IDO-GCN2 and autophagy in inflammation
por: McGaha, Tracy L.
Publicado: (2015)

IL-22 and IDO1 Affect Immunity and Tolerance to Murine and Human Vaginal Candidiasis
por: De Luca, Antonella, et al.
Publicado: (2013)

Differential Roles of IDO1 and IDO2 in T and B Cell Inflammatory Immune Responses
por: Merlo, Lauren M. F., et al.
Publicado: (2020)

USP14 promotes tryptophan metabolism and immune suppression by stabilizing IDO1 in colorectal cancer
por: Shi, Dongni, et al.
Publicado: (2022)

Microbial metabolites in colorectal tumorigenesis and cancer therapy
por: Liu, Yali, et al.
Publicado: (2023)

Exploitation of the IDO Pathway in the Therapy of Rheumatoid Arthritis
por: Williams, Richard O.
Publicado: (2013)

Trial watch: IDO inhibitors in cancer therapy
por: Le Naour, Julie, et al.
Publicado: (2020)

Salmonella-Mediated Therapy Targeting Indoleamine 2, 3-Dioxygenase 1 (IDO) Activates Innate Immunity and Mitigates Colorectal Cancer Growth
por: Phan, Thuy, et al.
Publicado: (2019)

IDO Vaccine Ablates Immune-Suppressive Myeloid Populations and Enhances Antitumor Effects Independent of Tumor Cell IDO Status
por: Nandre, Rahul, et al.
Publicado: (2022)

Significance of Apoptosis in the Process of Tumorigenesis in Colorectal Mucosa and Adenomas in FAP Patients
por: Weiß, Hildegard, et al.
Publicado: (1997)

Blockade of IDO-Kynurenine-AhR Axis Ameliorated Colitis-Associated Colon Cancer via Inhibiting Immune Tolerance
por: Zhang, Xin, et al.
Publicado: (2021)

The p53-inducible CLDN7 regulates colorectal tumorigenesis and has prognostic significance
por: Hou, Yichao, et al.
Publicado: (2020)

Expression profile of the human IDO1 protein, a cancer drug target involved in tumoral immune resistance
por: Vigneron, Nathalie, et al.
Publicado: (2015)

Indoleamine 2,3-Dioxygenase 1 (Ido1) Is Involved in the Control of Mouse Caput Epididymis Immune Environment
por: Jrad-Lamine, Aicha, et al.
Publicado: (2013)

Calcium Prevents Tumorigenesis in a Mouse Model of Colorectal Cancer
por: Wang, Ji-Lin, et al.
Publicado: (2011)

Serum Response Factor-Regulated IDO1/Kyn-Ahr Pathway Promotes Tumorigenesis of Oral Squamous Cell Carcinoma
por: Xu, Mingyan, et al.
Publicado: (2023)

IDO1, FAT10, IFI6, and GILT Are Involved in the Antiretroviral Activity of γ-Interferon and IDO1 Restricts Retrovirus Infection by Autophagy Enhancement
por: Kubo, Yoshinao, et al.
Publicado: (2022)

P53 prevent tumor invasion and metastasis by down-regulating IDO in lung cancer
por: Tang, Dongfang, et al.
Publicado: (2017)

Plac1 Is a Key Regulator of the Inflammatory Response and Immune Tolerance In Mammary Tumorigenesis
por: Yuan, Hongyan, et al.
Publicado: (2018)

Involvement of APC and K-ras mutation in non-polypoid colorectal tumorigenesis
por: Umetani, N, et al.
Publicado: (2000)

Immune combinational therapy targeting OX40 and IDO synergistically enhances efficacy of a cancer vaccine
por: Berrong, Zuzana, et al.
Publicado: (2014)

A Longitudinal Analysis of IDO and PDL1 Expression during Immune- or Targeted Therapy in Advanced Melanoma()
por: Krähenbühl, Lukas, et al.
Publicado: (2018)

Genetic Polymorphisms Affecting IDO1 or IDO2 Activity Differently Associate With Aspergillosis in Humans
por: Napolioni, Valerio, et al.
Publicado: (2019)

Objective measurement and clinical significance of IDO1 protein in hormone receptor-positive breast cancer
por: Carvajal-Hausdorf, Daniel E., et al.
Publicado: (2017)

Indoleamine 2,3 dioxygenase (IDO) level as a marker for significant coronary artery disease
por: Wongpraparut, Nattawut, et al.
Publicado: (2021)

Involvement of STAT3 in immune evasion during lung tumorigenesis
por: Kida, Hiroshi, et al.
Publicado: (2013)

IDO1/COX2 Expression Is Associated with Poor Prognosis in Colorectal Cancer Liver Oligometastases
por: Wu, Miaoqing, et al.
Publicado: (2023)

Decoding the intercellular communication network during tumorigenesis
por: An, Liwei, et al.
Publicado: (2022)

Prevention of Wogonin on Colorectal Cancer Tumorigenesis by Regulating p53 Nuclear Translocation
por: Feng, Qian, et al.
Publicado: (2018)

β-catenin in epithelial tumorigenesis
por: Lu, Tsai-Ling, et al.
Publicado: (2015)

Mycobiota dysbiosis and gastric tumorigenesis
por: Papon, Nicolas, et al.
Publicado: (2021)

Clonal Extinction Drives Tumorigenesis
por: Amaro, Adriana, et al.
Publicado: (2023)

Dendritic cell metabolism: immunity and tolerance
por: Vanherwegen, An-Sofie, et al.
Publicado: (2015)

Aging-associated increase in indoleamine 2,3-dioxygenase (IDO) activity appears to be unrelated to the transcription of the IDO1 or IDO2 genes in peripheral blood mononuclear cells
por: Marttila, Saara, et al.
Publicado: (2011)

Amyloid β neurotoxicity is IDO1–Kyn–AhR dependent and blocked by IDO1 inhibitor
por: Duan, Zhenzhen, et al.
Publicado: (2020)

Indoleamine 2,3‐dioxygenase (IDO)‐1 and IDO‐2 activity and severe course of COVID‐19
por: Guo, Lihui, et al.
Publicado: (2022)

Identification of an IDO1‐based immune classifier for survival prediction of upper tract urothelial carcinoma
por: Zhong, Wenlong, et al.
Publicado: (2022)

Contribution to Understanding the Mechanisms Involved in Biofilm Formation, Tolerance and Control
por: Simões, Lúcia Chaves, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_6k9vclqo1aarbmia9p3r4cocu2